Innovation Through Pioneering Technology SM


Call us today 212-583-0100

For billing information:

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Friday, December 15, 2006 ENZO Biochem Raises $46.0 Million in Registered Direct Offering
Monday, December 11, 2006 ENZO Biochem Reports Improved First Quarter Financial Results
Thursday, December 07, 2006 Discussion of Fiscal 2007 First Quarter Results
Thursday, November 30, 2006 U.S. Court Of Appeals Allows ENZO Biochem Patent Infringement Suit to Proceed
Wednesday, November 22, 2006 Third Annual Life Sciences Conference
Thursday, November 16, 2006 Patent on Basic DNA Gel
Monday, October 16, 2006 ENZO Biochem Reports Results for Fiscal 2006 and Fourth Quarter
Monday, October 16, 2006 ENZO Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
Friday, October 13, 2006 ENZO Biochem Acquires License to Six Key RNA Amplification Patents Complementary Product Line Based On Technology to Be Offered In Conjunction with Existing Microarray Labeling Systems
Friday, October 13, 2006 Enzo Biochem Reports Favorable Markman Ruling in Federal Court Upholding Key Patent Claim Terms
Thursday, October 12, 2006 Notice of Teleconference
Friday, October 06, 2006 ENZO Biochem Clinical Labs Announces Expanded Regional Services Contract With United Healthcare Group
Tuesday, September 19, 2006 ENZO Biochem Announces Settlement with Sigma-Aldrich in Contract and Patent Litigation
Friday, September 08, 2006 ENZO Named Senior Party in U.S. Patent & Trademark Office Proceeding ENZO Granted Interferences for Key Nucleic Acid Detection Technology
Tuesday, August 15, 2006 ENZO Biochem Reports Long Term Retention of Antisense RNA In Phase I Study Of Hiv-1 Infected Subjects Updated Report to International Aids Conference Calls Results “Significant”
Wednesday, July 19, 2006 ENZO Biochem Announces Approval For Phase II Double-Blind Clinical Trial Of Egs21 For Non-Alcoholic Steatohepatitis (Nash)
Press Details Wednesday, June 21, 2006 ENZO Biochem, Inc., Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Monday, June 12, 2006 ENZO Biochem To Present At Needham & Company Fifth Annual Biotechnology Conference
Friday, June 09, 2006 Enzo Biochem Reports Results For Third Fiscal Quarter
Thursday, June 08, 2006 ENZO Biochem Appoints Carl W. Balezentis, Ph.D., President Of Enzo Life Sciences Subsidiary
Thursday, June 08, 2006 ENZO Biochem Schedules Teleconference To Discuss Third Quarter Results
Tuesday, June 06, 2006 ENZO Biochem Appoints Andrew R. Crescenzo Senior Vice President Of Finance
Tuesday, May 23, 2006 ENZO Biochem Announces Plans to Produce Single Copy DNA Probes That Could Open Door to More Effective Treatment of Genetic Diseases and Cancer
Tuesday, March 14, 2006 ENZO Biochem Initiates Phase II Trial Of Immunomodulatory Compound For Crohn’s Disease
Monday, March 13, 2006 ENZO Biochem Reports Second Quarter Results
Friday, March 10, 2006 Discussion of Fiscal 2006 Second Quarter Results
Wednesday, March 01, 2006 ENZO Receives Approval To Commence HIV Clinical Trial
Tuesday, February 21, 2006 ENZO Awarded Patent For Phosphate Labeling For DNA Diagnostic And Medical Research Products
Friday, January 20, 2006 ENZO Biochem 2006 Annual Meeting of Shareholders webcast link:
Thursday, January 19, 2006 ENZO Biochem Awarded Patent Covering Processes For Producing Therapeutic Proteins Or RNAs In Living Cells
Thursday, January 19, 2006 ENZO Biochem Shareholders Elect Three Directors At Annual Meeting
Wednesday, January 18, 2006 ENZO Biochem, Inc. Announces Webcast Of Annual Meeting

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.